High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody-Reference-Cited by-同舟云学术

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Published:2005-08-15 Issue:16 Volume:11 Page:5920-5927
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Richman Carol M.,DeNardo Sally J.,O'Donnell Robert T.,Yuan Aina,Shen Sui,Goldstein Desiree S.,Tuscano Joseph M.,Wun Ted,Chew Helen K.,Lara Primo N.,Kukis David L.,Natarajan Arutselvan,Meares Claude F.,Lamborn Kathleen R.,DeNardo Gerald L.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Long-Acting [⁸⁹Zr]Zr-DFO GLP-1 PET Tracers with Increased Molar Activity and Reduced Kidney Accumulation;Journal of Medicinal Chemistry;2023-03-30

2. Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer;EJNMMI Radiopharmacy and Chemistry;2022-12-21

3. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives;Cancers;2022-01-27

4. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022

5. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022